Evidence map›Paper›PMID 25896551›Full record

ArticleEndocrine2015

Pituitary function and morphology in Fabry disease.

Luigi Maione, Fabio Tortora, Roberta Modica, Valeria Ramundo, Eleonora Riccio, Aurora Daniele, Maria Paola Belfiore, Annamaria Colao, Antonio Pisani, Antongiulio Faggiano

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Decreased trabecular bone score in patients affected by Fabry disease.Journal of endocrinological investigation · 2025
    Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Luigi MaioneSection of Endocrinology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. luigi.maione@unina.it.
Fabio TortoraInstitute of Clinical and Experimental Medicine, "F. Magrassi - A. Lanzara", Dipartimento di Diagnostica per Immagini, Second University of Naples, Naples, Italy.
Roberta ModicaSection of Endocrinology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Valeria RamundoSection of Endocrinology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Eleonora RiccioDepartment of Nephrology, University of Naples Federico II, Naples, Italy.
Aurora DanieleDipartimento di Scienze e Tecnologie Ambientali Biologiche Farmaceutiche, Second University of Naples, Naples, Italy.
Maria Paola BelfioreInstitute of Clinical and Experimental Medicine, "F. Magrassi - A. Lanzara", Dipartimento di Diagnostica per Immagini, Second University of Naples, Naples, Italy.
Annamaria ColaoSection of Endocrinology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Antonio PisaniDepartment of Nephrology, University of Naples Federico II, Naples, Italy.
Antongiulio FaggianoSection of Endocrinology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. afaggian@unina.it.
University of Naples Federico II · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine abnormalities are known to affect patients with Fabry disease (FD). Pituitary gland theoretically represents an ideal target for FD because of high vascularization and low proliferation rate. We explored pituitary morphology and function in a cohort of FD patients through a prospectic, monocentric study at an Academic Tertiary Center. The study population included 28 FD patients and 42 sex and age-matched normal subjects. The protocol included a contrast enhancement pituitary MRI, the assessment of pituitary hormones, anti-pituitary, and anti-hypothalamus antibodies. At pituitary MRI, an empty sella was found in 11 (39%) FD patients, and in 2 (5%) controls (p < 0.001). Pituitary volume was significantly smaller in FD than in controls (p < 0.001). Determinants of pituitary volume were age and alpha-galactosidase enzyme activity. Both parameters resulted independently correlated at multivariate analysis. Pituitary function was substantially preserved in FD patients. Empty sella is a common finding in patients with FD. The major prevalence in the elderly supports the hypothesis of a progressive pituitary shrinkage overtime. Pituitary function seems not to be impaired in FD. An endocrine workup with pituitary hormone assessment should be periodically performed in FD patients, who are already at risk of cardiovascular complications.

Indexed as

Pituitary DiseasesAdultEmpty Sella SyndromeFabry DiseaseFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedDiencephalic MRIEmpty sellaFabry diseasePituitary

Identifiers

PMID25896551
OpenAlexW2076498734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.